ALKS

#1227
Alkermes Inc. plc
33.98 USD
+0.68%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
33.84
34.03
Rango anual
25.16
36.48
Cambio diario
+0.68%
Variación mensual
+21.53%
Variación en los últimos 6 meses
+7.84%
Cambio anual
+23.74%
Cierres anteriores
33.75
Abrir
33.84
Bid
Ask
Mínimo
33.84
High
34.03
Volumen
203
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 5.66 B
  • Employee 2 050
  • Founded 1987
  • CEO Richard F. PopsRichard F. Pops
  • Website www.alkermes.com
  • Headquarter Ireland
  • FIGI UNKNOWN
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
19.57
Relación precio/flujo de caja
3.2

Alkermes plc

Alkermes plc is a fully-integrated biopharmaceutical company that focuses on developing medicines for psychiatric and neurological disorders. The company was founded in 1987 by Michael Wall. In September 2011 Alkermes, Inc. merged with Elan Drug Technologies, the former drug formulation and manufacturing division of Élan Corporation, plc. The company is headquartered in Dublin, and has an R&D center in Waltham, Massachusetts, and a manufacturing facility in Wilmington, Ohio.

Noticias